Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study
- Conditions
- Hepatitis B
- Registration Number
- NCT02548325
- Lead Sponsor
- Corporacion Parc Tauli
- Brief Summary
The aim of this study is to evaluate the prevalence of hepatitis B in Vallés Occidental. Also, describe the stage of the disease, and whether if they are under medical treatment or not.
- Detailed Description
The hepatitis B virus ( HBV ) is a global health problem . It is estimated that in the world there are about 350-400 million carriers of HBV surface antigen ( HBsAg ) 1 .
The prevalence in Spain is estimated at a 2-7 % and is considered a second intermediate prevalence.
For over 20 years, has carried out a program of primary prevention through universal vaccination against hepatitis B including it in the childhood vaccination schedule and has already been observed that in some estudi3 the prevalence has declined . For this reason , we want to evaluate what is the currently prevalence in our area of influence. There aren't recent studies to assess what is the current status of these patients ( how many , what risk factors which needs of treatment and with answer ...)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1001
- Patients with HBsAg + visited in Digestive/Hepatology outpatient visits and Hepatology of the participating hospitals
- Patients < 18 aged
- Duplicity on record
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevalence hepatitis B 12 months
- Secondary Outcome Measures
Name Time Method stage of the disease and if they are in treatment or not 1 day
Trial Locations
- Locations (1)
Mútua de Terrassa
🇪🇸Terrassa, Barcelona, Spain